Prolonged dual antiplatelet therapy with ticagrelor 60 mg twice daily in patients with a prior myocardial infarction: real-world insights on incidence and reasons for non-compliance
Real-world persistence with prolonged DAPT remains a challenge, often hindered by patient-driven discontinuation and adverse events. Enhanced patient education on therapy benefits and adherence may improve long-term outcomes.
Authors
- Patrizia Guarini
- Alessandra Scatteia (ORCID: https://orcid.org/0000-0003-4030-1126)
- Alberto Morello (ORCID: https://orcid.org/0009-0000-8781-5250)
- Salvatore A. Giordano (ORCID: https://orcid.org/0000-0001-5981-6870)
- Laura Adelaide Dalla Vecchia (ORCID: https://orcid.org/0000-0002-6516-0959)
- Angelo Silverio (ORCID: https://orcid.org/0000-0001-9749-8092)
- Beatrice De Maria (ORCID: https://orcid.org/0000-0001-5360-3137)
- Michele Cimmino (ORCID: https://orcid.org/0000-0001-6390-0178)
- Nicola Corcione (ORCID: https://orcid.org/0000-0001-7137-274X)
- Gennaro Galasso (ORCID: https://orcid.org/0000-0002-7265-7613)
- Pasquale Campana (ORCID: https://orcid.org/0000-0002-5011-1193)
- Francesco De Stefano
- Salvatore Severino
- Michele Albanese
Institutions
- University of Salerno (IT)
- Magna Graecia University (IT)
- Centro Studi Industriali (IT)
- Istituti Clinici Scientifici Maugeri (IT)
- Casa di Cura San Michele (IT)
- Clinica Mediterranea (IT)
- Villa Pineta Hospital (IT)
- Accredited Private Hospital Villa Regina (IT)
Publication Details
- Journal
- Minerva Cardiology and Angiology
- Published
- 2025-11-01
- DOI
- https://doi.org/10.23736/s2724-5683.25.06970-4
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00